Keywords: 6-OHDA; 6-hydroxydopamine; PD; Parkinson's disease; CPA; costophrenic angle; Respiration; Diaphragm; Radiography; Disease models; Behavior; Animal;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Hydrogen sulfide; Gasotransmitter; Sulfhydration; Neurodegeneration; Oxidative stress; Antioxidants; 3-MST; 3-mercaptopyruvate sulfurtransferase; 4-HNE; 4-hydroxynonenal; 6-OHDA; 6-hydroxydopamine; Aβ; β-Îmyloid; AD; Alzheimer's disease; ALS; Amyotro
Keywords: 6-OHDA; 6-hydroxydopamine; L-DOPA; L-3,4-dihydroxyphenylalanine; MB; methylene blue; MPP+; 1-methyl-4-phenylpyridinium; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; OD; optical density; p; probenecid; PD; Parkinson's disease; SNpc; substantia nig
Keywords: Parkinson's disease; Sex; Nigrostriatal degeneration; Motor symptoms; Non-motor symptoms; MPTP; 6-OHDA; Estradiol;
Keywords: Aβ; amyloid beta; AβO; Aβ oligomer; ACh; acetylcholine; AChE; acetylcholinesterase; AD; Alzheimer's disease; AGEs; advanced glycation end products; AND; age-related neurological disorder; Bax; Bcl-2-associated X protein; Bcl-2; B-cell lymphoma 2; BDNF;
Keywords: Parkinson's disease; Rodent models; Rodent behaviour; Animal models; Alpha-synuclein; LRRK2; GBA; 6-OHDA; Rotenone; MPTP; FBXO7; ATP13A2; VPS35; Parkin; PINK1; DJ-1;
Keywords: AcH; acetaldehyde; CTIQs; catechol isoquinolines; DA; dopamine; DMDHIQ+; 1,2-dimethyl-6,7-dihydroxyisoquinolinium ion; ISOP; isoproterenol; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MPP+; 1-Methyl-4-phenylpyridinium; N-Me-Sal; N-methyl-salsolino
Keywords: Parkinson's disease; 6-OHDA; Nrf2; NOR; SH-SY5Y cell;
Keywords: Etazolate; Parkinson's disease; 6-OHDA; Memory; Maze; Oxidative stress; BDNF;
Keywords: 6-OHDA; 6-hydroxyl-dopamine; DA; dopamine; DBS; deep brain stimulation; DL; dorsolateral; FSIs; fast spiking interneurons; H2O2; hydrogen peroxide; i.p; intraperitoneal; LFP; local field potential; MSNs; medium spiny projecting neurons; PB; phosphate buff
Keywords: OS; oxidative stress; ROS; reactive oxygen species; MG; methylglyoxal; glo 1; glyoxalase-1; glo 2; glyoxalase-2; AGEs; advanced glycation end products; ASD; autism spectrum disorder; GSH; reduced glutathione; cas-3; caspase-3; NeuN; neuronal specific nucl
Keywords: Parkinson's disease; L-DOPA-induced dyskinesia; 6-OHDA; MPTP; Animal models; Rodents;
Keywords: 5-HT; 5-hydroxytryptamine; 6-OHDA; 6-hydroxydopamine; AC; anterior cingulate; ADHD; attention deficit hyperactivity disorders; AES; Apathy Evaluation Scale; AI; Apathy Inventory; AS; Apathy Scale; BG; basal ganglia; D2R/D3R; D2/D3 dopamine receptors; D2R;
Keywords: AMPA; α-amino-3-hydroxy-5-methyl-4- isoxazole propionic acid; ASI; Axon-spine interface; Ca2+; calcium; CNS; Central nervous system; CS-EP; Corticostriatal-evoked potential; DBS; deep brain stimulation; DA; Dopamine; DARPP-32; dopamine-regulated neuronal
Keywords: Stress; Amyloid; Norepinephrine; Dopamine-β-hydroxylase; Depression; Adrenergic receptors; AD; Alzheimer's disease; HPA; hypothalamo-pituitary adrenal; PFC; prefrontal cortex; DMN; default mode network; SP; senile plaque; NFT; neurofibrillary tangle; MMS
Keywords: 6-OHDA; 6-hydroxydopamine; CA; catecholamine; CaMKII; Ca2+/calmodulin-dependent protein kinase II; CDK; cyclin-dependent kinase; CNS; central nervous system; DA; dopamine; ENS; enteric nervous system; ERK; extracellular signal regulated kinase; GI; gastro
Keywords: Parkinson's disease; Animal models; Poly I:C; LPS; 6-OHDA; Rotenone; Neuroinflammation; Toll-like-receptors; Cytokines;
Keywords: 6-OHDA; 6-hydroxydopamine; ABC; avidin-biotin-peroxidase complex; AIM; abnormal involuntary movement; DDS; dopamine dysregulation syndrome; IT; intratelencephalic; LID; levodopa-induced dyskinesia; PD; Parkinson's disease; PT; pyramidal tract; Dendritic
Keywords: DDS; dopamine dysregulation syndrome; PD; Parkinson's disease; NAc; nucleus accumbens; LID; levodopa induced dyskinesia; CPu; caudate and putamen; MSNs; medium spiny neurons; MFB; medial forebrain bundle; 6-OHDA; 6-hydroxydopamine; AIM; abnormal involunta
Keywords: DA; dopamine; i.c.v; intra-cerebro-ventricular; l-dopa; levodopa; MPTP; 1 méthyl-4-phenyl-1,2,3,6 terahydropyridine; 6-OHDA; 6-hydroxydopamine; PD; Parkinson's disease; SMBS; sodium metabisulfite; SNpc; substantia nigra pars compacta; Parkinson's disease
Keywords: Aging; Striatum; Substantia nigra; Dopamine; Calcitriol; 6-OHDA;
Keywords: 6-OHDA; 6-hydroxydopamine; CPu; caudate putamen; DAT; dopamine transporter; DTI; diffusion tensor imaging; dw-MRI; diffusion weighted MRI; FA; fractional anisotropy; FC; functional connectivity; FOV; field of view; GQI; generalized Q-ball imaging; iso; is
Keywords: Safflower; Flavonoid extract; Sub-chronic toxicity; SAFE; standardized safflower flavonoid extract; AHYB; anhydrosafflor yellow B; 6-OHDA; 6-hydroxydopamine; PD; Parkinson's disease;
Keywords: Parkinson's disease; 6-hydroxydopamine; Cerium oxide nanoparticles; Oxidative stress; Apoptosis; Striatal dopamine; 6-OHDA; 6-hydroxydopamine; PD; Parkinson's disease; CeO2NPs; cerium oxide nanoparticles; ROS; reactive oxygen species; TAC; total antioxida
Keywords: 6-OHDA; 6-hydroxydopamine; AP; anteroposterior; BG; basal ganglia; CV; coefficient of variation; DA; dopamine; DBS; deep brain stimulation; DV; dorsoventral; ECoG; electrocorticogram; EPN; entopeduncular nucleus; GP; globus pallidus; GPe; globus pallidus
Keywords: Baicalin; Baicalein; Flavonoids; Chemoprevention; Inflammatory diseases; 6-OHDA; 6-hydroxydopamine; 12-LOX; 12-lipoxygenase; AIDS; acquired immunodeficiency disorder syndrome; AhR; aryl hydrocarbon receptor; AIH; autoimmune hepatitis; AICAR; 5-aminoimidaz
Keywords: 6-OHDA; 6-hydroxydopamine; ACC; anterior cingulate cortex; BLA; basolateral amygdala; CeA; central amygdala; CV; Cresyl Violet; GABA; gamma-aminobutyric acid; LAT; limb-use asymmetry test; MFB; medical forebrain bundle; mPFC; medial prefrontal cortex; NE;
Keywords: HCC; hepatocellular carcinoma; SNS; sympathetic nervous system; KCs; Kupffer cells; TH; tyrosine hydroxylase; AR; adrenergic receptor; DEN; diethylnitrosamine; 6-OHDA; 6-hydroxydopamine; GdCl3; gadolinium (III) chloride; IL-1α; interleukin-1 alpha; IL-1Î
Keywords: 6-OHDA; 6-hydroxydopamine; Aβ; amyloid-β; AD; Alzheimer disease; ALS; amyotrophic lateral sclerosis; APOE4; apolipoprotein E4; APP; amyloid precursor protein; ASCL1; achaete-scute family basic helix-loop-helix transcription factor 1; ATP; adenosine trip
Keywords: 6-OHDA; 6-hydroxydopamine; pAcH3; p-acetylated-histone H3; DIV; day(s) in vitro; HDAC; histone deacetylase; LDH; lactate dehydrogenase; MTT; Thiazolyl Blue Tetrazolium Bromide; N; number of repetitions; Romidepsin; Neuroblastoma; Cell death; Epigenetic re
Keywords: BBB; blood-brain barrier; CSF; cerebral spinal fluid; COX1; cyclo-oxygenase 1; COX2; cyclo-oxygenase 2; CRP; C reactive protein; DA; dopamine; EGF; Epidermal growth factor; FACIT; functional assessment of chronic illness therapy; FcγRII; Fc gamma recepto
Keywords: 3-HK; 3-hydroxykynurenine; 6-OHDA; 6-hydroxydopamine; A; Amygdala; ACMSD; 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase; AD; Alzheimer's disease; AD; Anterodorsal nucleus (Thalamus); α-syn; Alpha-synuclein; CCL2; Chemokine (CC motif) ligand 2;
Keywords: 6-OHDA; 6-hydroxydopamine; AADC; aromatic amino acid decarboxylase; AAV; adeno-associated virus; ADX88178; 5-methyl-N-(4-methylpyrimidin-2-yl)-4-(1H-pyrazol-4-yl)thiazol-2amine; ASCs; adipose stem/stromal cells; BDNF; brain-derived neurotrophic factor; BM
Keywords: Dopamine; Ecstasy; Methamphetamine; METH; 3,4-Methylenedioxymethamphetamine; MDMA; Mouse; Neurodegeneration; Neuroinflammation neurotoxicity; Non-human primate; Rat; AC; adenylyl cyclase; AcbSh; nucleus accumbens shell; AcbC; nucleus accumbens core; cAMP;
Keywords: 4-HNE; 4-hydroxy-2-nonenal; 6-OHDA; 6-hydroxydopamine; BSO; buthioninesulfoximine; DFO; Deferoxamine; DMT1; divalent metal transporter 1; ELISA; enzyme-linked immunosorbent assay; FPN1; Ferroportin 1; IRE; iron responsive element; IRP; iron regulatory pro
Keywords: 2OG; 2-oxoglutarate; 5-HIAA; 5-hydroxyindoleacetic acid; 5-HT; 5-hydroxytryptamine; 5-HTP; 5-hydroxytryptophan; 5mC; 5-methylcytosine; 6-OHDA; 6-hydroxydopamine; α-KG; α-ketoglutarate; AAAD; aromatic-l-amino acid decarboxylase; AANAT; aralkylamine N-ace
Keywords: 5-HT2C receptor; serotonin2C receptor; DRN; dorsal raphe nucleus; MRN; medial raphe nucleus; DA; Dopamine; 6-OHDA; 6-hydroxydopamine; HFS; high frequency stimulation; NAc; Nucleus Accumbens; STN; subthalamic nucleus; EPN; entopeduncular nucleus; GPCRs; G-
Keywords: 6-OHDA; 6-hydroxydopamine; α-syn; α-synuclein; ACC; Anterior Cingulate Cortex; ADMA; asymmetric dimethylarginine; Alda-1; N-(1,3-Benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide; Aldh1/Aldh2; aldehyde dehydrogenases 1/2; ALDH2; mitochondrial aldehyde dehyd
Keywords: 5-HT; serotonine; 6-OHDA; 6-hydroxydopamine; AIM; abnormal involuntary movement; CSF; cerebrospinal fluid; DA; dopamine; DBS; deep brain stimulation; EP; enteropedoncular nucleus; GPe; external part of globus pallidus; GPi; internal part of globus pallidu
Keywords: Polyphenols; Antibiotics; Antioxidants; PACAP; Aβ; β-amyloid; AD; Alzheimer's disease; AMPK; AMP-activated protein kinase; BBB; blood-brain barrier; BDNF; brain-derived neurotrophic factor; CAT; catalase; CNS; central nervous system; COX-2; cyclooxyge
Keywords: 2,4-D; dichlorophenoxyacetic acid; [35S]TBPS; [35S]tertiary-butylbicyclophosphorothionate; 3-NP; 3-nitropropionic acid; 4CL; 4-coumarate: CoA ligase; 4-O-MH; 4-O-methylhonokiol; 6-OHDA; 6-hydroxydopamine; 8-oxo-dG; 8-oxo-2â²-deoxyguanosine; AChE; acetylc
Keywords: BBB; blood brain barrier; 6-OHDA; 6-hydroxydopamine; PD; Parkinson's disease; H215O; 15O-water; FDG; 18F-fluorodeoxyglucose; CBF; cerebral blood flow; CMR; cerebral metabolic rate for glucose; GP; globus pallidus; LID; levodopa-induced dyskinesia; VOI; vo
Keywords: Neurodegeneration; Flavonoids; Antioxidant; Signalling pathways; Neuroinflammation; AD; Alzheimer's disease; PD; Parkinson's disease; HD; Huntington's disease; ALS; amyotrophic lateral sclerosis; MS; multiple sclerosis; DA; dopamine agonist; IFN; interfer
Keywords: L; Dopa (levedopa); MAO; inhibitors (monoamine oxidase B); COMPT; inhibitors (catechol-o-methyl transferase); MPTP; (1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine); MPPP; (1-Methyl-4-phenyl-4-propionoxypiperidine); MPDP; (1-Methyl-4-phenyl-1, 2-dihydrox
Keywords: Maternal separation; Anxiety; Fluvoxamine maleate; 6-OHDA; Dopamine; Parkinson’s disease
Keywords: Parkinson's disease; Estrogen; MPTP; 6-OHDA; Dopamine; Striatum; PPT; G1; GPER1; Finasteride; Dutasteride; Neuroprotection
Keywords: Parkinson disease; Rat; Ultrasonic vocalization; Levodopa; Vocal exercise; 6-OHDA
Keywords: Incentive salience; Dopamine; Sign-tracking; Goal-tracking; CS; conditioned stimulus; US; unconditioned stimulus; CR; conditioned response; 6-OHDA; 6-hydroxdopamine;
Keywords: Apomorphine-induced rotation; Differentiation; Dopaminergic neurons; Dopamine secretion; Fetal liver MSCs; 6-OHDA; Parkinson disease
Keywords: 5-HIAA; 5-hydroxyindoleacetic acid; 6-OHDA; 6-hydroxydopamine; AMG; amygdala; CP; caudate-putamen; DAB; diaminobenzidine; DAT; dopamine transporter; DG; dentate gyrus; DR; dorsal raphe; HB; habenula; ir; immunoreactive; NAC; nucleus accumbens; NET; noradr